China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 6.32 billion. The enterprise value is 4.67 billion.
| Market Cap | 6.32B |
| Enterprise Value | 4.67B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
SHE:301333 has 95.80 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 95.80M |
| Shares Outstanding | 95.80M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | 12.34% |
| Owned by Institutions (%) | 17.56% |
| Float | 38.00M |
Valuation Ratios
The trailing PE ratio is 52.86 and the forward PE ratio is 38.14.
| PE Ratio | 52.86 |
| Forward PE | 38.14 |
| PS Ratio | 6.73 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | 137.99 |
| P/OCF Ratio | 99.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.64, with an EV/FCF ratio of 102.03.
| EV / Earnings | 38.87 |
| EV / Sales | 4.98 |
| EV / EBITDA | 36.64 |
| EV / EBIT | 40.54 |
| EV / FCF | 102.03 |
Financial Position
The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.81 |
| Quick Ratio | 5.65 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.36 |
| Interest Coverage | 47.64 |
Financial Efficiency
Return on equity (ROE) is 6.26% and return on invested capital (ROIC) is 32.44%.
| Return on Equity (ROE) | 6.26% |
| Return on Assets (ROA) | 3.06% |
| Return on Invested Capital (ROIC) | 32.44% |
| Return on Capital Employed (ROCE) | 5.68% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | 355,125 |
| Profits Per Employee | 45,462 |
| Employee Count | 2,645 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 10.44 |
Taxes
In the past 12 months, SHE:301333 has paid 12.86 million in taxes.
| Income Tax | 12.86M |
| Effective Tax Rate | 9.53% |
Stock Price Statistics
The stock price has increased by +20.57% in the last 52 weeks. The beta is 0.40, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +20.57% |
| 50-Day Moving Average | 56.54 |
| 200-Day Moving Average | 60.13 |
| Relative Strength Index (RSI) | 67.08 |
| Average Volume (20 Days) | 3,232,599 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 939.31 million and earned 120.25 million in profits. Earnings per share was 1.25.
| Revenue | 939.31M |
| Gross Profit | 295.11M |
| Operating Income | 115.30M |
| Pretax Income | 134.98M |
| Net Income | 120.25M |
| EBITDA | 114.61M |
| EBIT | 115.30M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 1.67 billion in cash and 16.32 million in debt, with a net cash position of 1.66 billion or 17.29 per share.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 16.32M |
| Net Cash | 1.66B |
| Net Cash Per Share | 17.29 |
| Equity (Book Value) | 2.01B |
| Book Value Per Share | 20.86 |
| Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was 63.60 million and capital expenditures -17.79 million, giving a free cash flow of 45.81 million.
| Operating Cash Flow | 63.60M |
| Capital Expenditures | -17.79M |
| Depreciation & Amortization | -691,025 |
| Net Borrowing | -13.44M |
| Free Cash Flow | 45.81M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 31.42%, with operating and profit margins of 12.27% and 12.80%.
| Gross Margin | 31.42% |
| Operating Margin | 12.27% |
| Pretax Margin | 14.37% |
| Profit Margin | 12.80% |
| EBITDA Margin | 12.20% |
| EBIT Margin | 12.27% |
| FCF Margin | 4.88% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.24%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.24% |
| Dividend Growth (YoY) | 0.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 17.62% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.20% |
| Shareholder Yield | -0.96% |
| Earnings Yield | 1.90% |
| FCF Yield | 0.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301333 has an Altman Z-Score of 10.52 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.52 |
| Piotroski F-Score | 5 |